90Yttrium Ibritumomab Tiuxetan as First Line Treatment for Follicular Lymphoma First Results from an International Phase II Clinical Trial
(2010) 52nd Annual Meeting of the American-Society-of-Hematology (ASH) In Blood 116(21). p.261-261
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1917716
- author
- organization
- publishing date
- 2010
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Blood
- volume
- 116
- issue
- 21
- pages
- 261 - 261
- publisher
- American Society of Hematology
- conference name
- 52nd Annual Meeting of the American-Society-of-Hematology (ASH)
- conference dates
- 2010-12-04 - 2010-12-07
- external identifiers
-
- wos:000285025202591
- ISSN
- 1528-0020
- language
- English
- LU publication?
- yes
- id
- bd9938f8-15d2-4498-9765-d0b7bd38e735 (old id 1917716)
- date added to LUP
- 2016-04-01 10:21:02
- date last changed
- 2018-11-21 19:44:38
@misc{bd9938f8-15d2-4498-9765-d0b7bd38e735, author = {{Scholz, Christian W. and Pinto, Antonello and Linkesch, Werner and Lindén, Ola and Viardot, Andreas and Keller, Ulrich and Hess, Georg and Lerch, Kristina and Frigeri, Ferdinando and Arcamone, Manuela and Frericks, Bernd and Pott, Christiane and Puzzutto, Antonto}}, issn = {{1528-0020}}, language = {{eng}}, note = {{Conference Abstract}}, number = {{21}}, pages = {{261--261}}, publisher = {{American Society of Hematology}}, series = {{Blood}}, title = {{90Yttrium Ibritumomab Tiuxetan as First Line Treatment for Follicular Lymphoma First Results from an International Phase II Clinical Trial}}, volume = {{116}}, year = {{2010}}, }